Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesThe effects of an olmesartan medoxomil–based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and older
The Journal of Clinical Hypertension, 07/01/09
Kereiakes DJ et al. – An olmesartan medoxomil (OM)-based treatment algorithm effectively lowers blood pressure (BP) in an elderly pt population throughout 24-hr dosing interval without compromising tolerability.
Methods- Study of the effect of OM ± hydrochlorothiazide (HCTZ) on mean 24-hr ambulatory BP, mean seated cuff (Se)BP, and SeBP goal achievement in hypertensive pts age ≥65 yrs
- After 2- to 3-wk placebo run-in, OM 20 mg, uptitrated to 40 mg, then added HCTZ 12.5 mg to 25 mg stepwise at 3-wk intervals if SeBP remained ≥120/70 mm Hg
- Primary endpoint: change from baseline in mean 24-hr ambulatory systolic BP
- At study end, mean 24-hr ambulatory BP decreased by 25.7/12.3 mm Hg (150 pts) and mean SeBP by 25.4/10.5 mm Hg (176 pts)
- Drug-related treatment-emergent adverse events, most commonly dizziness (3.4%), hypotension (2.2%), and headache (1.1%), in 11.8% of pts
Related Articles
Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke
Hypertension Research, 11/11/09
Relevance Score: 87%
Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension
Hypertension Research, 11/10/09
Relevance Score: 84%
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/10/09
Relevance Score: 80%
Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner
Nephrology Dialysis Transplantation, 10/08/09
Relevance Score: 80%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/20/09
Human Parvovirus B19 Infection in Patients with Coronary Atherosclerosis
Archives of Medical Research, 12/20/09
Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Is Increased in Human Left Ventricle after Acute Myocardial Infarction
Archives of Medical Research, 12/20/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/20/09
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/19/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/19/09
Today in Geriatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
A review of heart failure management in the elderly population
The American Journal of Geriatric Pharmacotherapy, 12/18/09
Rest-Activity Patterns in Institutionalized Korean Older Adults with Dementia: A Pilot Study
Journal of Gerontological Nursing, 12/18/09
Older Patients in the Emergency Department: What Are the Risks
Journal of Gerontological Nursing, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor